Fig. 1: Comparison of the mean log2 of anti-RBD IgG, MNA90 and IFN-γ from 1 month response after the 2nd dose (T−1) and after the 3rd dose (T1). | Nature Communications

Fig. 1: Comparison of the mean log2 of anti-RBD IgG, MNA90 and IFN-γ from 1 month response after the 2nd dose (T−1) and after the 3rd dose (T1).

From: Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

Fig. 1: Comparison of the mean log2 of anti-RBD IgG, MNA90 and IFN-γ from 1 month response after the 2nd dose (T−1) and after the 3rd dose (T1).

A–C Mean log2 change of anti-RBD IgG (A),MNA90 (B) and IFN-γ (C) from 1 month response after the 2nd dose (T−1) and after the 3rd dose (T1) [Paired t-test, 2-sided no adjustment for multiple comparisons]. Mean Log2 changes of anti-RBD IgG (A) and MNA90 (B) significantly increased from T-1 to T1 (p < 0.0001; p < 0.0001; respectively but IFN-γ (C, p = 0.39) Source data are provided as a Source Data file.

Back to article page